MetLife posts record adjusted EPS as group benefits underwriting runs ahead of target

MetLife reported Q3 2026 adjusted EPS of $2.85, a record, with group benefits segment earnings up 15% YoY to $523M. Sales rose 12% YoY, with strong underwriting results. Net income surged 187% to $2.4B, but this was largely due to derivative accounting. Adjusted ROE was 19.6%, and adjusted book value per share increased 5% to $59.41.

Original reporting
Published Nov 5, 2026, 11:21 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 12:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MetLife posts record adjusted EPS as group benefits underwriting runs ahead of target — source image
Decision brief

The 30-second read

$METBullishHigh
01

Why it matters

The earnings beat and improved underwriting margins provide a clear catalyst for short‑term price appreciation.

02

Market read

First‑report earnings with material numbers; likely to move MET stock and influence the broader insurance sector.

03

What to watch

Potential volatility from interest‑rate driven derivative gains/losses could affect future results.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

MetLife's Q3 2026 earnings release includes adjusted EPS record, strong group benefits underwriting, and guidance on mortality ratios.

Company-level read

Ticker impact

$METBullishHigh confidence
Context

MetLife reported record adjusted EPS and strong group benefits underwriting results, beating prior expectations and providing new guidance.

Expected impact

likely upward pressure as market prices in the earnings beat and improved mortality ratios

Evidence & confidence

The article presents first‑report earnings numbers, adjusted EPS record, and guidance that exceeds prior ranges, which are material new data for traders.

Market effects

Highlights strength in the U.S. insurance sector, especially group benefits underwriting.

Positive for U.S. financial services equities.

Reinforces confidence in large-cap insurers worldwide.

Counterpoint

If higher mortality ratios re‑emerge, earnings could soften, limiting upside.

Key entities

  • MetLife

    U.S. insurer reporting record adjusted EPS and strong underwriting performance.

Related articles

$METHighAI 8/10

MetLife Q3 Earnings Call Highlights

MetLife reported Q3 earnings, with variable investment income of $1.5B for the first nine months, on track to exceed its $1.6B full-year guidance. Group Benefits and Retirement adjusted earnings rose 14% and 12% respectively. International operations saw mixed results, with Asia up 21% and Latin America down 5%. The company repurchased $650M in shares in Q3 and is on track to meet its full-year targets.

$METMedAI 8/10

Chesnara bags £1.7bn MetLife UK closed life book in latest takeover

Chesnara agreed to acquire MetLife UK's closed-book life insurance business for £1.7bn in assets, subject to regulatory approval. The deal is expected to generate £90m in lifetime cashflows, with £45m added to Own Funds and Contractual Service Margin. Chesnara aims to strengthen its UK business and future cash generation. Analysts note the deal boosts long-term capital generation without significantly impacting Chesnara's acquisition firepower.

$METMed

Chesnara To Buy MetLife's Closed-book UK Life Insurance Firm; Terms Not Disclosed

Chesnara plc (CSN.L) agreed to buy MetLife's (MET) closed-book UK life insurance unit, MetLife UK Limited, for an undisclosed sum. The deal, expected to close in early 2027, will add 18,000 policies and £1.7 billion in assets. Chesnara anticipates £45 million boost to Own Funds and Contractual Service Margin, with £90 million in lifetime cash flows, half within five years. Shares rose 1.15%.

$METHighAI 9/10

MetLife (MET) Q3 2026 Earnings Call Transcript

MetLife (MET) reported Q3 2026 adjusted earnings of $1.8B ($2.85 EPS), up 17% YoY. Adjusted EPS ex-items rose 22%, with ROE at 19.6%. Growth was driven by Group Benefits, Retirement & Income Solutions, and Asia. The company repurchased $650M in shares, bringing YTD capital return to $3.5B.